Nachrichten zur DexCom Inc. Aktie

Image source: The Motley Fool.DATEApril 30, 2026, 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Jacob Steven LeachChief Financial…

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for quarterly results, helped…

DexCom (DXCM) delivered earnings and revenue surprises of +19.66% and +1.31%, respectively, for the quarter ended March 2026. Do the…

DexComs Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could…

DexComs expanding CGM market, G7 rollout, and global growth momentum position it for gains, despite pricing pressure and near-term margin…

DexCom (DXCM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…

…

DexCom (DXCM) delivered earnings and revenue surprises of +4.62% and +0.64%, respectively, for the quarter ended December 2025. Do the…

DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Jabils stock rose over 3% after analysts denied rumors of losing Dexcom business, reaffirming a Strong Buy and highlighting the…

Shares of electronics manufacturing services provider Jabil (NYSE:JBL) jumped 3.5% in the morning session after an analyst reiterated a Strong…

Jabil’s (JBL) recent stock weakness does not reflect any negative surprises, as earnings, guidance, and management commentary were in line,…

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

NEW YORK, Nov. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

RADNOR, Pa., Nov. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)…

Dexcom: director Heller sells $58,766 in shares…

DexComs growth rate has been improving, but that hasnt been enough of a reason for investors to buy up the…

Dexcom Inc. (DXCM) ist ein Pionier und führendes Unternehmen im Bereich der kontinuierlichen Glukosemessung (CGM, Continuous Glucose Monitoring) und hat…

The Complaint alleges DexCom made unauthorized G6 and G7 design changes, overstated reliability, and downplayed resulting health and regulatory risks.…

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action…

DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the…

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital…

Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth.Gross…

Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended…

DexCom Q2 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo…

Key PointsDexCom has barely scratched the surface of its niche in the diabetes market.As a result of industry challenges, the…

Key PointsThe Invesco QQQ Trust is focused on the best and most valuable growth stocks on the Nasdaq exchange.The Schwab…

DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a…

Manchmal ist der beste Weg, einen Fehler zu beheben, darauf zu setzen. Genau das tut DexCom, der Hersteller von kontinuierlichen…

Die Entscheidung von DexCom, den Markt für Typ-2-Diabetes anzugehen, war nicht fehlerhaft. Das Problem lag in der Umsetzung der Strategie…

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffetts…

Geschäftstreiber:Dexcom (DGX) Das Unternehmen gilt als Anbieter der branchenweit fortschrittlichsten kontinuierlichen Blutzuckermesssensoren (CGMs), die Diabetiker beim Insulinmanagement unterstützten.... …

Dexcom Deutschland GmbH: Mainz (ots) - - Das einfach zu bedienende [1] Dexcom G7 lässt sich jetzt mit Omnipod 5,…

Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth,…

Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy…

Investors typically want to beat the market over the long run. Though its not an easy task, it certainly is…

DexCom shares surge as Q1 revenue beats expectations…

SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has…

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its…

In this podcast, Motley Fool analysts talk about economic uncertainty, airlines, building materials, and assorted spirits. Motley Fool analyst Asit Sharma…

With equity markets reeling due to President Donald Trumps tariffs, many investors are taking this opportunity to buy shares of…

DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and expanding…

What should investors do during a market downturn? Some might resort to panic selling, but thats hardly a good strategy.…

DexCom shares rise on FDA clearance for new CGM system…

DexComs recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring.…

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The…

Equity markets started 2025 pretty well, but things havent been so rosy in the past couple of months. The tech-heavy…